miR-17-5p and miR-20a also repress BMPRII expression, influencing its regulation in the IL-6/STAT3 signaling axis, an important inflammatory pathway implicated in PAH pathology (184, 185). This evidence concerns the gene IL6 and pulmonary arterial hypertension.